Csenge Advisory Group’s Cardinal Health CAH Stock Holding History

Csenge Advisory Group’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-46	Closed	-$2K	–	382
2018 Q3	$2K	Buy	+46	New	+$2.35K	﹤0.01%	737

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Csenge Advisory Group's CAH Position: Q4 2018 in Review

Csenge Advisory Group sold out of Cardinal Health (CAH) in Q4 2018, closing a stake of 46 shares — an estimated $2K sold.

Csenge Advisory Group first reported a position in CAH in Q3 2018 and held it in 1 quarter. The position peaked at $2K in Q3 2018. 718 funds tracked by Wall St. Rank hold CAH as of Q4 2018.

Csenge Advisory Group reported no remaining Cardinal Health position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 46 Cardinal Health shares in Q4 2018, an estimated $2K.
Csenge Advisory Group first reported a position in Cardinal Health in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's Cardinal Health position peaked at $2K in Q3 2018.
718 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.